Investors
We announced our full year and fourth quarter 2025 results on Wednesday, 4 February.
Press releases
- Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
- Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA
- TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation

GSK Global links
Visit our Global site for additional features









